SCHEMBL21167798

SCHEMBL21167798

COc1cccc(-c2ccc(N)c(NCc3c[nH]c4ncccc34)n2)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FGFR1 P11362 1/20 0.54
FGFR4 P22455 1/20 0.54
SYK P43405 4/20 0.52
CYP3A4 P08684 7/20 0.44
CYP2C19 P33261 7/20 0.44
USP2 O75604 6/20 0.44
CYP1A2 P05177 6/20 0.44
CYP2D6 P10635 6/20 0.44
TSHR P16473 5/20 0.44
LMNA P02545 5/20 0.44
MEN1 O00255 4/20 0.44
KMT2A Q03164 4/20 0.44
CLK4 Q9HAZ1 4/20 0.44
MAPK1 P28482 3/20 0.44
CYP2C9 P11712 5/20 0.44
HIF1A Q16665 1/20 0.44
ALOX15 P16050 1/20 0.43
DRD4 P21917 1/20 0.43
DRD3 P35462 1/20 0.43
HSD17B10 Q99714 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24591093 0.81 FGFR1 (0.53) FGFR1FGFR4SYKCYP3A4CYP2C19
SCHEMBL22475864 0.80 GPR84 (0.43) FGFR1FGFR4SYKCYP3A4CYP2C19
SCHEMBL21167708 0.78 SYK (0.53) SYKCYP3A4CYP2C19USP2CYP1A2
SCHEMBL22475696 0.78 MET (0.44) SYKCYP3A4CYP2C19CDC7ROCK2
SCHEMBL21167697 0.76 MTNR1A (0.44) SYKCYP3A4CYP2C19KIT
SCHEMBL16882541 0.74 FGFR1 (0.53) FGFR1FGFR4SYKCYP3A4CYP1A2
SCHEMBL12693327 0.74 FGFR1 (0.53) FGFR1FGFR4SYKDRD4DRD3
SCHEMBL857087 0.72 CDC7 (0.64) FGFR1FGFR4CLK4DYRK1AKIT
SCHEMBL22475837 0.72 MAP4K3 (0.49) PAK4PIM1
SCHEMBL857805 0.71 FGFR1 (1.00) FGFR1FGFR4CYP3A4CYP2C19KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3511330-B1 SYNTHETIC INTERMEDIATE USEFUL IN THE PREPARATION OF TRIAZOLOPYRIDINE C-MET INHIBITORS HUTCHISON MEDIPHARMA LTD (CN) 2020-09-30 EP disclosed
EP-3511330-A1 SYNTHETIC INTERMEDIATE USEFUL IN THE PREPARATION OF TRIAZOLOPYRIDINE C-MET INHIBITORS Hutchison Medipharma Limited (CN) 2019-07-17 EP disclosed